Authors' Response to Weng et al.'s Comment on "Association of GLP1-Receptor Agonists with Risk of Hepatocellular Carcinoma: A Retrospective Cohort Study".
Saved in:
| Title: | Authors' Response to Weng et al.'s Comment on "Association of GLP1-Receptor Agonists with Risk of Hepatocellular Carcinoma: A Retrospective Cohort Study". |
|---|---|
| Authors: | Mansi IA; Education Services, Orlando VA Healthcare System, 13800 Veterans Way, Orlando, FL, 32827, USA. Ishak.mansi@va.gov.; Department of Internal Medicine, University of Central Florida, Greater Orlando, FL, USA. Ishak.mansi@va.gov., Boktor M; Division of Digestive & Liver Diseases, University of Texas Southwestern Medical Center, Dallas, TX, USA. |
| Source: | Drug safety [Drug Saf] 2026 Feb; Vol. 49 (2), pp. 255-257. Date of Electronic Publication: 2025 Sep 26. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1179-1942 |
|---|---|
| DOI: | 10.1007/s40264-025-01616-8 |
